ROYALTY PHARMA PLC shareholders Q3 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bank Pictet & Cie (Europe) AG 50,000$1,357,0000.05%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 2,026,131$54,989,1950.05%
Inspire Investing, LLC 13,413$364,0290.05%
Tredje AP-fonden 108,406$2,942,1380.04%
Cubist Systematic Strategies, LLC 214,448$5,820,1060.04%
Teza Capital Management LLC 16,543$448,9770.04%
PGGM Investments 87,484$2,3740.04%
SEVEN EIGHT CAPITAL, LP 12,830$348,2060.04%
Mendota Financial Group, LLC 1,441$39,1090.04%
JANUS HENDERSON GROUP PLC 2,236,396$60,696,1200.04%
Transamerica Financial Advisors, Inc. 10,597$2880.04%
USS Investment Management Ltd 133,602$3,626,6260.04%
Hillsdale Investment Management Inc. 15,400$417,9560.04%
SYNOVUS FINANCIAL CORP 119,741$3,249,7700.04%
State of Wyoming 5,986$162,4600.04%
AQR Capital Management 635,683$17,010,8650.04%
Koshinski Asset Management, Inc. 11,370$308,5820.04%
Point72 Middle East FZE 39,519$1,072,5580.04%
Tower Research Capital LLC (TRC) 38,443$1,043,3430.03%
Bridgewater Associates 193,176$5,242,7970.03%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.